Congenital Disorder of Glycosylation, Type IIq
CDG2Q

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 1 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Cerebral palsy nervous 100 % 24784932 2024-05-08
Corpus callosum thining nervous 100 % 24784932 2024-05-08
Cerebral atrophy nervous 100 % 24784932 2024-05-08
Seizures nervous 100 % 24784932 2024-05-08
Hypocupremia circulatory 100 % 24784932 2024-05-08
Hypoceruloplasminemia circulatory 100 % 24784932 2024-05-08
Pituitary gland atrophy nervous 100 % 24784932 2024-05-08
Microcephaly nervous 100 % 24784932 2024-05-08
Developmental delay nervous 100 % 24784932 2024-05-08



List of references:


Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congenital disorder of glycosylation.
H Kodera, N Ando, I Yuasa, Y Wada, Y Tsurusaki, M Nakashima, N Miyake, S Saitoh, N Matsumoto, H Saitsu,



Clinical genetics - May 2015